Cargando…
Evaluation of bone marrow aspirates in patients with acute myeloid leukemia at day 14 of induction therapy
BACKGROUND: Early assessment of response to chemotherapy in acute myeloid leukemia may be performed by examining bone marrow aspirate (BMA) or biopsy (BMB); a hypocellular bone marrow sample indicates adequate anti-leukemic activity. We sought to evaluate the quantitative and qualitative assessment...
Autores principales: | Souto Filho, João Tadeu D, Loureiro, Monique M, Pulcheri, Wolmar, Morais, José Carlos, Nucci, Marcio, Portugal, Rodrigo D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513973/ https://www.ncbi.nlm.nih.gov/pubmed/26205005 http://dx.doi.org/10.1186/s13000-015-0365-2 |
Ejemplares similares
-
Current treatment preferences in acute myeloid leukemia: a survey in Brazil
por: Portugal, Rodrigo Doyle, et al.
Publicado: (2020) -
Impact of Day 14 Bone Marrow Biopsy on Re-Induction Decisions and Prediction of a Complete Response in Acute Myeloid Leukemia Cases
por: Alsaleh, Khalid, et al.
Publicado: (2018) -
PB1824: IMPACT OF DAY 15 BONE MARROW ASPIRATION ON PREDICTION OF COMPLETE REMISSION AND RELAPSE IN ACUTE MYELOID LEUKEMIA
por: Kharrat, R., et al.
Publicado: (2022) -
Diagnostic-driven antifungal therapy in neutropenic patients using the D-index and serial serum galactomannan testing()
por: Garnica, Marcia, et al.
Publicado: (2016) -
Contrast-induced thrombocytopenia following percutaneous coronary intervention
por: Ferreira, Roberto Muniz, et al.
Publicado: (2017)